TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) Investor Securities Class Action Lawsuit 11/08/2022

  • If you purchased a significant amount of shares of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) between March 10, 2021 and October 4, 2022, and / or if you purchased any NASDAQ: EIGR shares prior to March 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: January 9, 2023. NASDAQ: EIGR investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

April 10, 2023 - The case was voluntarilly dismissed. November 08, 2022 - An investor in shares of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Eiger BioPharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)